Benzinga - Mon, 08 Mar 2021 06:08:58 -0400
Benzinga - Fri, 05 Mar 2021 13:47:47 -0400
Benzinga - Fri, 05 Mar 2021 13:02:17 -0400
Benzinga - Thu, 04 Mar 2021 18:44:48 -0400
Benzinga - Thu, 04 Mar 2021 17:41:04 -0400
Benzinga - Thu, 04 Mar 2021 17:04:56 -0400
Benzinga - Thu, 04 Mar 2021 05:07:02 -0400
Benzinga - Wed, 20 Jan 2021 06:12:02 -0400
Benzinga - Tue, 19 Jan 2021 13:07:03 -0400
load more
Sector: Health Care.Industry: Biotechnology
Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-04
REV
Q4 2020Est.ActualSurprise
EPS-1.480-2.500 -1.0200
REV34.000M38.160M4.160M

Related Companies

TickerCompanyChg %Mkt Cap
ACORAcorda Therapeutics0%38.9M

Acorda Therapeutics Company Questions & Answers

Q

How do I buy Acorda Therapeutics (ACOR) stock?

A

You can purchase shares of Acorda Therapeutics (NASDAQ: ACOR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Acorda Therapeutics's (ACOR) main competitors?

A

Other companies in Acorda Therapeutics’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Immuron (NASDAQ:IMRN) and Midatech Pharma (NASDAQ:MTP).

Q

What is the target price for Acorda Therapeutics?

A

There is no analysis for Acorda Therapeutics

Q

How much is Acorda Therapeutics (ACOR) stock ?

A

The stock price for Acorda Therapeutics (NASDAQ: ACOR) is $4.1 last updated Today at 8:00:02 PM.

Q

When is the next Acorda Therapeutics (ACOR) dividend?

A

There are no upcoming dividends for Acorda Therapeutics.

Q

When is Acorda Therapeutics (NASDAQ:ACOR) reporting earnings?

A
Acorda Therapeutics’s Q1 earnings are confirmed after-market from now on May 4, 2021.
Q

When is the upcoming split for ACOR?

A

There is no upcoming split for Acorda Therapeutics.